Philip Vickers

Philip Vickers

Direktor/Vorstandsmitglied bei AKEBIA THERAPEUTICS, INC.
66 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Philip J.
Vickers
currently serves as President, Chief Executive Officer & Director at Solu Therapeutics, Inc., Director at Northern Mosaic LP, and Director at Akebia Therapeutics, Inc. (starting 2026).
Former roles include President, Chief Executive Officer & Director at Northern Biologics, Inc. (2017–2020), President, Chief Executive Officer & Director at Faze Medicines, Inc. (2021–2022), President, Director & Chief Scientific Officer at Resolvyx Pharmaceuticals, Inc. (2009–2011), Independent Director at Revance Therapeutics, Inc. (2015–2023), Director at Neusentis Ltd., Independent Director at AVROBIO, Inc. (2019–2024), Global Head-Research & Development at Shire Plc (2013–2017), Principal at Boehringer Ingelheim Corp., VP & Head-Pfizer Research Technology Center at Pfizer (St. Louis), and Principal at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at the University of Salford and a doctorate from the University of Toronto.

Aktive Positionen von Philip Vickers

UnternehmenPositionBeginn
AKEBIA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.04.2026
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender 01.09.2023

Ehemalige bekannte Positionen von Philip Vickers

UnternehmenPositionEnde
TECTONIC THERAPEUTIC, INC. Direktor/Vorstandsmitglied 20.05.2024
REVANCE THERAPEUTICS, INC. Direktor/Vorstandsmitglied 03.05.2023
Vorstandsvorsitzender 01.11.2022
Vorstandsvorsitzender 01.12.2020
SHIRE Technik-/Wissenschafts-/F&E-Leiter 01.06.2017
Sehen Sie sich die Erfahrung von Philip Vickers im Detail an

Ausbildung von Philip Vickers

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Philip Vickers